References
- Backman, G., Hunt, P., Khosla, R., Jaramillo-Strouss, C., Fikre, B. M., Rumble, C., … Vladescu, C. (2008). Health systems and the right to health: An assessment of 194 countries. The Lancet, 372(9655), 2047–2085. doi: 10.1016/S0140-6736(08)61781-X
- Bui, A. L., Lavado, R. F., Johnson, E. K., Brooks, B. P., Freeman, M. K., Graves, C. M., … Dieleman, J. L. (2015). National health accounts data from 1996 to 2010: A systematic review. Bulletin of the World Health Organization, 93(8), 566–576D. doi: 10.2471/BLT.14.145235
- Chahed, M. K., & Arfa, C. (2014). Monitoring and evaluating progress towards Universal Health Coverage in Tunisia. PLoS Medicine, 11(9), e1001729. doi: 10.1371/journal.pmed.1001729
- Constitute. (n.d.). Retrieved from https://www.constituteproject.org/content/about?lang=en
- Ewen, M., Zweekhorst, M., Regeer, B., & Laing, R., (2017). Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases. PloS One, 12(2), e0171284. doi: 10.1371/journal.pone.0171284
- Faden, L., Vialle-Valentin, C., Ross-Degnan, D., & Wagner, A. (2011). The role of health insurance in the cost-effective use of medicines (WHO/Health Action International Review series on pharmaceutical pricing policies and interventions. No. 2). Retrieved from http://haiweb.org/wp-content/uploads/2015/08/Health-insurance-final-May2011a1.pdf
- Flood, C., & Gross, A. (2014). Litigating the right to health: What can we learn from a comparative law and health care systems approach. Health and Human Rights, 16(2), E62–E72. Retrieved from https://cdn2.sph.harvard.edu/wp-content/uploads/sites/125/2014/12/Flood-final.pdf
- Ghiasi, G., Rashidian, A., Kebriaeezadeh, A., & Salamzadeh, J. (2016). The impact of the sanctions made against Iran on availability to asthma medicines in Tehran. Iranian Journal of Pharmaceutical Research, 15(3), 567–571. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27980593
- Gotham, D., Onarheim, K. H., & Barber, M. J. (2016). How the MDGs gave up on measuring access to medicines. The Lancet Global Health, 4(5), e296–e297. doi: 10.1016/S2214-109X(16)00066-8
- Gray, A. L., & Suleman, F. (2015). The relevance of systematic reviews on pharmaceutical policy to low- and middle-income countries. International Journal of Clinical Pharmacy, 37(5), 717–725. doi: 10.1007/s11096-015-0156-6
- Gray, A. L., Wirtz, V. J., ‘t Hoen, E. F. M., Reich, M. R., & Hogerzeil, H. V. (2015). Essential medicines are still essential. The Lancet, 386(10004), 1601–1603. doi: 10.1016/S0140-6736(15)00514-0
- Health Action International. (n.d.). Medicine prices, availability, affordability & price components [online database]. Retrieved from http://www.haiweb.org/medicineprices/
- Hodgkin, C., Carandang, E. D., Fresle, D. A., & Hogerzeil, H. V. (Eds.). (2003). How to develop and implement a national drug policy (Second). Geneva: World Health Organization. Retrieved from http://apps.who.int/iris/bitstream/handle/10665/42423/924154547X.pdf?sequence=1
- Hosseinpoor, A. R., Bergen, N., Schlotheuber, A., Gacic-Dobo, M., Hansen, P. M., Senouci, K., … Barros, A. J. D. (2016). State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: A multicountry study of household health surveys. The Lancet Global Health, 4(9), e617–e626. doi: 10.1016/S2214-109X(16)30141-3
- International Covenant on Economic, Social and Cultural Rights. (1966). UN general assembly. Retrieved from http://www.ohchr.org/Documents/ProfessionalInterest/cescr.pdf
- Kaplan, W. A., Ritz, L. S., Vitello, M., & Wirtz, V. J. (2012). Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010. Health Policy, 106(3), 211–224. doi: 10.1016/j.healthpol.2012.04.015
- Kheirandish, M., Rashidian, A., & Bigdeli, M. (2015). A news media analysis of economic sanction effects on access to medicine in Iran. Journal of Research in Pharmacy Practice, 4(4), 199–205. doi: 10.4103/2279-042X.167042
- Leopold, C., Mantel-Teeuwisse, A. K., Vogler, S., Valkova, S., de Joncheere, K., Leufkens, H. G., … Laing, R. (2014). Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries. Bulletin of the World Health Organization, 92(9), 630–640D. doi: 10.2471/BLT.13.129114
- OECD. (2009). Health at a Glance 2009 - pharmaceutical expenditure. Retrieved from http://dx.doi.org/10.1787/health_glance-2009-en
- OECD. (2015). Health at a Glance 2015 - financing of pharmaceutical expenditure. Retrieved from goo.gl/xHuXG6
- Office of the High Commissioner for Human Rights. (2012). Human rights indicators: A guide to measurement and implementation [Document HR/PUB/12/5]. Retrieved from http://www.ohchr.org/Documents/Publications/Human_rights_indicators_en.pdf
- Perehudoff, K., Toebes, B., & Hogerzeil, H. (2016). A human rights-based approach to the reimbursement of expensive medicines. Bulletin of the World Health Organization, 94(12), 935–936. doi: 10.2471/BLT.15.166371
- Strategic Advisory Group of Experts on Immunization. (2014). Assessment report of the global vaccine action plan. Retrieved from http://www.who.int/immunization/global_vaccine_action_plan/SAGE_DoV_GVAP_Assessment_report_2014_English.pdf?ua=1
- United Nations. (2015). The Millennium development goals report 2015. New York. Retrieved from http://www.un.org/millenniumgoals/2015_MDG_Report/pdf/MDG 2015 rev (July 1).pdf
- United Nations Committee on Economic, Social and Cultural Rights (CESCR). (2000). General comment no. 14 on the right to the highest attainable standard of health. Geneva: United Nations. Document No. E/C.12/2000/4. Retrieved from http://goo.gl/1c6vMf
- United Nations General Assembly. (2015). Resolution on transforming our world: The 2030 agenda for sustainable development. Geneva: United Nations. Retrieved from http://www.un.org/en/development/desa/population/migration/generalassembly/docs/globalcompact/A_RES_70_1_E.pdf
- Vogler, S., Zimmermann, N., Leopold, C., & de Joncheere, K. (2011). Pharmaceutical policies in European countries in response to the global financial crisis. Southern Med Review. doi: 10.5655/smr.v4i2.1004
- WHO Expert Committee on the Selection and Use of Essential Medicines. (2003). The selection and use of essential medicines (WHO Technical Report Series, No. 914). Geneva: World Health Organization. Retrieved from http://apps.who.int/medicinedocs/en/d/Js4875e/
- Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., De Joncheere, C. P., Ewen, M. A., … Reich, M. R. (2016). Essential medicines for universal health coverage. The Lancet, 74. doi: 10.1016/S0140-6736(16)31599-9
- World Health Organization. (2008). Medium term strategic plan 2008–2013. Geneva. Retrieved from http://apps.who.int/gb/ebwha/pdf_files/MTSP-08-13-PPB-10-11/mtsp-3en.pdf
- World Health Organization. (2015). Development of country profiles and monitoring of the pharmaceutical situation in countries [website]. Retrieved from http://www.who.int/medicines/areas/coordination/coordination_assessment/en/
- World Health Organization. (2018). Vaccine-preventable diseases: Monitoring system [website]. Retrieved from http://apps.who.int/immunization_monitoring/globalsummary
- World Health Organization. (n.d.). Essential medicines and health products information Portal [website]. Retrieved from http://apps.who.int/medicinedocs/en/
- World Health Organization, & UNICEF. (2017). WHO UNICEF coverage of DTP3 [online database]. Retrieved from http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragedtp3.html
- World Health Organization, & World Bank. (2017). Tracking universal health coverage: 2017 global monitoring report. Geneva. Retrieved from http://pubdocs.worldbank.org/en/193371513169798347/2017-global-monitoring-report.pdf
- Yamin, A. E., & Parra-Vera, O. (2009). How do courts set health policy? The case of the Colombian constitutional court. PLoS Medicine, 6(2), e1000032. doi: 10.1371/journal.pmed.1000032